HCC Patients After Curative Treatment With Low HBV Viral Load
1 clinical trials · Condition
◉ Watch HCC Patients After Curative Treatment With Low HBV Viral Load
| Record | Firm | Date |
|---|---|---|
| Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence (NCT04290936) | Taipei Veterans General Hospital, Taiwan | 2020-10-16 |
Track HCC Patients After Curative Treatment With Low HBV Viral Load automatically
Every clearance here is in the API, with alerts when new ones post.